Catalyst Wire Dossier Catalyst Wire Dossier

Tipifarnib (Zarnestra)

tipifarnib · Johnson & Johnson
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tipifarnib (Zarnestra), covering 2010-04-27 to 2010-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Study of Tipifarnib as Postconsolidation Therapy for Acute Myeloid Leukemia in Patients 60 Years and Older [Phase 2]

See pricing